In this study, we hypothesized that the HMC3 cells, upon stimulation with anti-inflammatory cytokines (IL-4, IL-13, IL-10, TGFβ, CCL2) released from cancer cells, will show an increased expression of immuno-suppressive and tumor-supportive proteins and associated pathways. The gene discussed is CCL2; the disease is cancer.